BURNING ISSUES
The 'Pharma-Crime' Wave: Rise of the Pill Mills (2010)
Updated May 26, 2026
Discover how the 'Pharma-Crime' wave of 2010 transformed the opioid crisis, the role of pill mills, and the forensic tools developed to track and prevent...
Latest Stories
INDIAN STOCK MARKETS
The 'Silver Economy' Boom: Healthcare and Insurance Stocks Lead Consumption Shift
Updated May 26, 2026
Discover how the Silver Economy India is driving growth in healthcare, insurance, and senior living sectors. A deep dive into the stocks leading this demographic...
US STOCK MARKETS
GLP-1 2.0: The Oral Bioavailability Breakthrough
Updated May 26, 2026
Discover the future of Oral GLP-1 Stocks. Learn how the breakthrough in oral bioavailability is expanding the weight-loss market and impacting healthcare investments on the...
US STOCK MARKETS
Generative Biology Boom: The 'Bio-NASDAQ' Resurgence via AI-Designed Proteins
Updated May 26, 2026
Discover the Bio-NASDAQ Resurgence driven by generative biology and AI-designed proteins. Learn why biotech stocks are outperforming and what the future holds for investors.
BIOLOGY
FDA Approval of 'Eros-7': The First Neuro-Peptide for Emotional Bonding
Updated May 26, 2026
Explore the revolutionary FDA approval of Eros-7, a synthetic neuro-peptide for emotional bonding. Learn about its science, clinical uses, and the ethics of bio-hacking love.
TECHNOLOGY
Pharma Q3 Earnings: USFDA Compliance Costs Weigh on Mid-Cap Margins
Updated May 26, 2026
Analyze the Q3 FY26 pharma earnings where USFDA Compliance Costs are impacting mid-cap margins. Explore the divergence between large-cap growth and mid-cap regulatory struggles.
TECHNOLOGY
FDA Fast-Tracks Oxy-Bond: The World's First Connection-Enhancing Nasal Spray
Updated May 26, 2026
Discover the science and ethics of Oxy-Bond nasal spray, the world's first FDA fast-tracked connection-enhancing drug for intimacy and marriage counseling.
INDIAN STOCK MARKETS
large-cap biotechs: investment insights for modern portfolios
Updated May 27, 2026
A concise guide to investing in large-cap biotechs, balancing resilience with risk in a dynamic healthcare market.
INDIAN STOCK MARKETS
Murae Organiser Share Soars 3.5% Amidst Market Plunge
Updated May 27, 2026
Murae Organiser share surged 3.5% defying market plunge. Company turns profitable, showing strong resilience. Know why!
TECHNOLOGY
Breakthrough: Making Affordable Antiviral Drugs a Reality
Updated May 27, 2026
A 19-year-old chemist has revolutionized galidesivir production, paving the way for affordable antiviral drugs that can combat deadly viruses.
BANKING & FINANCE
Lilly Obesity Pill: A New Contender in Weight Loss Treatments
Updated May 27, 2026
Discover how the Lilly obesity pill aims to reshape weight loss treatments, achieving an 11% reduction in body weight.
BANKING & FINANCE
Aether Industries Stock Analysis: Growth Challenges and Investment Potential
Updated May 27, 2026
A detailed analysis of Aether Industries stock covering growth contract manufacturing and investment potential. Learn about the company's strengths and risks.
BANKING & FINANCE
Roche to Invest $50 Billion in US Over Five Years
Updated May 27, 2026
Roche plans to invest $50 billion in the US over the next five years creating jobs and expanding its presence.
BANKING & FINANCE
Eli Lilly's $27 Billion US Manufacturing Investment: Jobs Impact and Concerns
Updated May 27, 2026
Eli Lilly's $27 billion investment in US manufacturing will create thousands of jobs but may impact drug prices. Learn more.
BANKING & FINANCE
Eli Lilly's $27 Billion US Manufacturing Investment: Jobs Impact and Concerns
Updated May 27, 2026
Eli Lilly's $27 billion investment in US manufacturing will create 13000 jobs. Learn about the impact concerns and future of pharmaceutical production in the US....
ANALYSIS
Laurus Labs Stock Plunges 10%: Profit-Taking After Strong Q3 Earnings
Updated May 27, 2026
Laurus Labs shares dropped 14% due to profit-booking after strong Q3 results. US aid concerns also impacted the stock. Laurus Labs Stock Plunge explained.
ANALYSIS
Syngene Stock Decline: Demand Delay Impacts Q3 Results and Future Outlook
Updated May 27, 2026
Syngene International's stock price dropped significantly after a revised full-year forecast due to slower-than-expected demand recovery. Learn more about the Syngene stock decline.
ANALYSIS
US Global Health Policy: Threats and Opportunities for International Cooperation
Updated May 27, 2026
Analyzing the impact of US global health policy changes on international cooperation and national security. Learn about the threats and opportunities. US Global Health Policy.